65
3
1
22
3
Cat. No. | Product Name | ||
---|---|---|---|
L1710 | 抗COVID-19化合物库 | 1133 compounds | |
1133 种对SARS-CoV-2有抑制作用或潜在抑制作用的化合物集合,可用于高通量和高内涵筛选; |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T77652 |
SARS-CoV-2 3CLpro-IN-20
|
Antiviral; SARS-CoV | Immunology/Inflammation; Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-20 是一种共价的 SARS-CoV-2 3CLpro 抑制剂(IC50s: 0.43 μM,)。SARS-CoV-2 3CLpro-IN-20 具有潜在的抗病毒活性。 | |||
T79659 |
SARS-CoV-2 3CLpro-IN-16
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-16为一种共价 SARS-CoV-2 3CLpro 抑制剂,抑制 3CLpro 活性,通过与Cys145形成共价键实现其抑制作用。 | |||
T9351 |
Nirmatrelvir
|
SARS-CoV | Microbiology/Virology |
Nirmatrelvir (PF-07321332) 是一种 SARS-CoV 3CLPRO 抑制剂,一种胰蛋白酶样蛋白酶抑制剂,具有有效性和口服活性。Nirmatrelvir 对 SARS-CoV-2 病毒有针对性,可研究 COVID-19。 | |||
T61774 |
SARS 3CLpro-IN-1
|
Others | Others |
SARS 3CLpro-IN-1 (Compound 3b) is a stereo-specific SARS 3CL protease inhibitor that belongs to the octahydroisochromene scaffold. It demonstrates inhibition against the P1 site imidazole, with an IC50 value of 95 μM [1]. | |||
T79676 |
SARS-CoV-2 3CLpro-IN-21
|
Virus Protease | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-21(Compound D6)作为一种抑制剂,不可逆且共价地作用于SARS-CoV-2 3CLpro,展现出0.03μM的IC50值。该化合物同样对SARS-CoV-1 3CLpro具有抑制效果,其IC50为0.12 μM。 | |||
T72370 |
SARS-CoV-2 3CLpro-IN-6
|
Others | Others |
SARS-CoV-2 3CLpro-IN-6 是 SARS-CoV-2 3CL 蛋白酶的可逆共价抑制剂。SARS-CoV-2 3CLpro-IN-6 对 SARS-CoV-2 3CLpro 具有强效抑制活性,IC50值为 4.9 μM。SARS-CoV-2 3CLpro-IN-6 可用于 COVID-19 的研究。 | |||
T72371 |
SARS-CoV-2 3CLpro-IN-7
|
Others | Others |
SARS-CoV-2 3CLpro-IN-7 是一种可逆的共价SARS-CoV-2 3CL 蛋白酶抑制剂,IC50值为 1.4 µM。 | |||
T62734 |
SARS-CoV-2 3CLpro-IN-4
|
Others | Others |
SARS-CoV-2 3CLpro-IN-4 (Compound 5g) is a multifunctional inhibitor of SARS CoV-2 3CLpro, exhibiting antiviral, antibacterial, and antifungal activities. | |||
T79660 |
SARS-CoV-2 3CLpro-IN-17
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-17 (Compound 3h)为选择性SARS-CoV-2 3CLpro抑制剂,具有0.322μM的IC50s值。 | |||
T79462 |
SARS-CoV-2 3CLpro-IN-14
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-14(compound 11j)为口服活性SARS-CoV-2 3CLpro抑制剂,于Vero E6细胞中对SARS-CoV-2展现出高效抗活性(EC50=0.18 μM),且具备低细胞毒性(CC50>50 μM)。 | |||
T63385 |
SARS-CoV-2 3CLpro-IN-2
|
Others | Others |
SARS-CoV-2 3CLpro-IN-2 是 3CL 蛋白酶对有效抑制剂,对SARS-CoV-2疾病表现出研究潜力。 | |||
T79376 |
SARS-CoV-2 3CLpro-IN-19
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-19 (Compound C5a)为非共价、非肽类SARS-CoV-2 3CLpro抑制剂,具IC50s值为0.7μM。该化合物对Omicron亚变体(包括BA.5、BQ.1.1及XBB.1.5)在人细胞内的感染显示出具有广谱抗病毒活性,其EC50值介于30-69 nM。 | |||
T72312 |
SARS-CoV-2 3CLpro-IN-10
|
Others | Others |
SARS-CoV-2 3CLpro-IN-10(5d)为一种有效的抗 SARS-CoV-2 3CL 蛋白酶抑制剂,其IC50值仅为190 nM,同时对SARS-CoV-1的IC50值为790 nM,对MERS-CoV的IC50值则为70 nM,显示出广谱的抗病毒活性。 | |||
T63679 |
SARS-CoV-2 3CLpro-IN-3
|
Others | Others |
SARS-CoV-2 3CLpro-IN-3 是 SARS CoV-2 3CLpro 抑制剂,表现出抗病毒(antiviral)、抗细菌(antibacterial)、抗真菌(antifungal)效果。 | |||
T72364 | SARS-CoV-2 3CLpro-IN-5 | SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-5 是一种针对 3C样蛋白酶3CLpro 的共价抑制剂,其抑制活性的 IC50 为 3.8 nM。该化合物的口服生物利用度(BA)为 9.0%,可用于 COVID-19 研究。 | |||
T79661 |
SARS-CoV-2 3CLpro-IN-18
|
SARS-CoV | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-18(Compound 3C)为一种共价SARS-CoV-2 3CLpro抑制剂,具有0.478 μM的IC50值。在Vero E6细胞中对SARS-CoV-2展现出2.499 μM的EC50抑制活性,并显示出较低的细胞毒性(CC50> 200 μM)。 | |||
T80657 |
SARS-CoV-2 3CLpro-IN-15
|
Virus Protease | Microbiology/Virology |
SARS-CoV-2 3CLpro-IN-15(compound a)为β-硝基苯乙烯型抑制剂,专门针对SARS-CoV-2的3CL蛋白酶(3CLpro)而设计。该化合物能有效抑制病毒的复制转录过程,是研发抗COVID-19候选先导化合物的关键因素。 | |||
T63537 |
SARS-CoV-2 3CLpro-IN-1
|
Others | Others |
SARS-CoV-2 3CLpro-IN-1 (Compound 14c) is a highly potent inhibitor specifically designed to target and inhibit the activity of SARS-CoV-2 3CL pro, which is a cysteine-protease found in the main coronaviruses. This particular enzyme has been recognized as a highly promising target for the development of effective antiviral drugs. Therefore, SARS-CoV-2 3CLpro-IN-1 holds significant potential for advancing research and development in the field of infectious diseases [1]. | |||
T74807 |
SARS-CoV-2 3CLpro-IN-13
|
Others | Others |
SARS-CoV-2 3CLpro-IN-13是一种针对SARS-CoV-2 3CL蛋白酶抑制剂,表现出有效的抗冠状病毒活性,其IC50值达21 nM。 | |||
T72313 |
SARS-CoV-2 3CLpro-IN-11
|
Others | Others |
SARS-CoV-2 3CLpro-IN-11(11d)为一种针对SARS-CoV-2 3CL蛋白酶的有效抑制剂,具备IC50值140 nM,并对SARS-CoV-1和MERS-CoV分别展现出IC50值240 nM与70 nM的抑制活性,显示出其广谱的抗病毒能力。 | |||
T9458 |
PF-00835231
|
SARS-CoV | Microbiology/Virology |
PF-00835231 是一种 CoV-2 半胱氨酸 3C 样蛋白酶抑制剂,对 SARS CoV-2 和 SARS CoV-1 3CLpro 的 IC50 分别为 0.27 nM 和 4 nM。它用于抗 SARS-CoV-2/COVID-19 的研究。 | |||
T5188 |
GC376 sodium
|
SARS-CoV | Microbiology/Virology |
GC376 sodium 是一种 3C 样蛋白酶 (3CLpro) 抑制剂,IC50 值范围为 0.49~4.35 μM。 | |||
T8371 |
ML188
|
Virus Protease; SARS-CoV | Microbiology/Virology |
ML188是一种选择性非共价 SARS-CoV3CLpro 抑制剂,具有抗病毒活性,IC50为 1.5 μM。 | |||
T9672 |
GRL-0496
|
SARS-CoV | Microbiology/Virology |
GRL-0496 是氯吡啶酯衍生物,是有效的 SARS-CoV 3CLpro 抑制剂,IC50为 30 nM。GRL-0496显示出抗 SARS-CoV 病毒活性,EC50为 6.9 μM。 | |||
T69535 |
GRL-0820
SARS-CoV-2-IN-6 |
SARS-CoV | Microbiology/Virology |
GRL-0820 (SARS-CoV-2-IN-6) 是一种高效的 SARS-CoV-2 3CLpro 抑制剂,可用于研究新型冠状病毒感染。 | |||
T4578 |
Tipranavir
PNU-140690 |
SARS-CoV; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Tipranavir 是一种蛋白酶抑制剂,对1种以上蛋白酶抑制剂耐药的HIV-1具有抑制作用 。Tipranavir 可有效抑制 HIV-1 蛋白酶 酶活性和二聚化,对抗多种蛋白酶抑制剂(PI)的HIV-1分离株具有有效的活性(IC50 为 66-410 nM)。Tipranavir 对SARS-CoV-2 3CLpro 活性有抑制作用。 | |||
T4474 |
Asunaprevir
BMS-650032,阿那匹韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Asunaprevir (BMS-650032) 是一种有口服活性的 HCV NS3 蛋白酶抑制剂,IC50值为 0.2 nM-3.5 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T4686 |
Simeprevir
TMC435,西咪匹韦,TMC-435350,Olysio |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Simeprevir (TMC435) 是一种有效的 HCV NS3/4A 蛋白酶抑制剂,抑制 HCV 复制,EC50 为 7.8 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T60095 |
CCF0058981
|
SARS-CoV | Microbiology/Virology |
CCF0058981 (CCF981) 是3-氯苯基类似物,是一种非共价 SARS-CoV-2 3CLpro(SC2)抑制剂,IC50为 68 nM。CCF0058981 抑制 SC1 (SARS-CoV-1 3CLpro),IC50为 19 nM。CCF0058981 具有抗病毒功效,具有用于 COVID-19 研究的潜力。 | |||
T5126 |
Glecaprevir
ABT-493 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Glecaprevir (ABT-493) 是一种新型的 HCV NS3/4A 蛋白酶抑制剂,其 IC50值在 3.5 和 11.3 nM 之间。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 4.09 μM。 | |||
T6388 |
Amprenavir
141W94,安普那韦,Prozei,KVX-478,VX-478,安瑞那韦 |
SARS-CoV; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Amprenavir (KVX-478) 是一种 HIV 蛋白酶抑制剂,Ki 为0.6 nM。它也是 SARS-CoV 3CLpro 抑制剂,IC50为 1.09 μM。 | |||
T7903 |
Saquinavir
Ro 31-8959,沙奎那韦 |
SARS-CoV; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Saquinavir (Ro 31-8959) 是一种 HIV 蛋白酶抑制剂,可研究逆转录病毒。它也是 SARS-CoV 3CLpro 抑制剂,IC50为 1.36 μM。 | |||
T6190 |
Telaprevir
VX-950,LY-570310,Incivek,MP-424,特拉匹韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Telaprevir (Incivek) 是一种选择性可逆的HCV NS3-4A 蛋白酶抑制剂,作用于基因 1型 (H 株) NS3 蛋白酶结构域和 NS4A 辅因子肽,Ki 为 7 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T0100L |
Atazanavir
Zrivada,Reyataz,Latazanavir,阿扎那韦,BMS-232632 |
P450; SARS-CoV; HIV Protease; P-gp | Membrane transporter/Ion channel; Metabolism; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Atazanavir (BMS-232632) 是一种高选择性的HIV-1蛋白酶抑制剂,可研究艾滋病毒感染。它也是SARS-CoV 3CLpro 的抑制剂,IC50为 3.49 μM。它是CYP3A4的底物和抑制剂,也是P-糖蛋白的抑制剂和诱导剂。 | |||
T5863 |
Indinavir sulfate
L735524 sulfate,MK-639 sulfate,硫酸茚地那韦 |
SARS-CoV; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Indinavir sulfate (L735524 sulfate) 是一种 HIV 蛋白酶抑制剂。它抑制 HIV-1 蛋白酶,IC50 值为 0.41 nM,Ki 值为 0.24 nM。它也是SARS-CoV 3CLpro 抑制剂,IC50为 1.71 μM。 | |||
T22394 |
Paritaprevir
ABT450,ABT-450,帕利普韦,Veruprevir |
HCV Protease | Microbiology/Virology; Proteases/Proteasome |
Paritaprevir (ABT450) 是一种非结构蛋白 3/4A 蛋白酶抑制剂,对 HCV 1a 和 HCV 1b 的 EC50 值分别为 1 和 0.21 nM。它也是SARS-CoV 3CLpro 的抑制剂,IC50为 1.31 μM。 | |||
T6025 |
Danoprevir
R7227,丹诺普韦,ITMN-191,RG7227,RO5190591 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Danoprevir (RG7227) 是具有口服活性的NS3/4A 蛋白酶抑制剂,IC50值为 0.29 nM。它抑制 HCV 基因型 1a, 1b, 4, 5, 6 (IC50s=0.2-0.4 nM) 和 2b, 3a (IC50s=1.6, 3.5 nM)。它也是SARS-CoV 3CLpro 的抑制剂,IC50为 0.05 μM。 | |||
T1525 |
Ritonavir
RTV,利托那韦,Abbott 84538,A 84538,ABT 538 |
Apoptosis; SARS-CoV; HIV Protease | Apoptosis; Microbiology/Virology; Proteases/Proteasome |
Ritonavir (ABT 538) 是一种 HIV 蛋白酶抑制剂,可研究 HIV 感染和 AIDS 。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 1.61 μM。 | |||
T0100 |
Atazanavir sulfate
阿扎那韦硫酸盐,BMS-232632,BMS-232632 sulfate,硫酸阿扎那韦 |
P450; SARS-CoV; HIV Protease; P-gp | Membrane transporter/Ion channel; Metabolism; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Atazanavir sulfate (BMS-232632 sulfate) 是一种氮杂肽和 HIV 蛋白酶抑制剂,与其他抗 HIV 药物联合用于治疗 HIV 感染和艾滋病。它也是SARS-CoV 3CLpro 抑制剂,IC50为 3.49 μM。 | |||
T4988 |
Boceprevir
SCH 503034,EBP 520,波普瑞韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Boceprevir (SCH 503034) 是一种口服有效的选择性 HCV NS3 蛋白酶抑制剂。在酶试验中的 Ki 为 14 nM,在基于细胞的复制子试验中 EC90 为 350 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T1623 |
Lopinavir
ABT-378,洛匹那韦 |
SARS-CoV; HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Lopinavir (ABT-378) 是一种选择性肽模拟 HIV-1 蛋白酶的高效抑制剂。它通过阻止 HIV-1 的成熟而起作用,从而阻断其感染性。它也是 SARS-CoV 3CLpro 的抑制剂。 | |||
T4547 |
Grazoprevir
MK-5172 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Grazoprevir (MK-5172) 是一种丙型肝炎病毒 NS3/4a 蛋白酶的选择性抑制剂,具有跨基因型和耐药变体的广泛活性,对 gt1b、gt1a、gt2a、gt2b 和 gt3a 的Ki 分别为 0.01 nM、0.01 nM、0.08 nM、0.15 nM 和 0.90 nM。它也是 SARS-CoV-2 3CLpro 抑制剂。 | |||
T3334 |
Velpatasvir
GS-5816,维帕他韦 |
HCV Protease; SARS-CoV | Microbiology/Virology; Proteases/Proteasome |
Velpatasvir (GS-5816) 是一种的 HCV NS5A 抑制剂。它也是 SARS-CoV 3CLpro 的抑制剂,IC50为 2.16 μM。 | |||
T9716 |
Ensitrelvir
S-217622 |
SARS-CoV | Microbiology/Virology |
Ensitrelvir (S-217622) 是首个口服有效的、非共价的、非肽的SARS-CoV-2 3CL 蛋白酶抑制剂,IC50为13 nM。 | |||
T14968 |
Cinanserin hydrochloride
SQ 10643 |
Influenza Virus; 5-HT Receptor | GPCR/G Protein; Microbiology/Virology; Neuroscience |
Cinanserin hydrochloride (SQ 10643) 是一种高亲和力拮抗剂,对 5-HT2 受体的Ki 值为 41 nM。它也是严重急性呼吸综合征冠状病毒的 3C 样蛋白酶抑制剂。 | |||
T6738 |
Z-FA-FMK
|
SARS-CoV; Cysteine Protease | Microbiology/Virology; Proteases/Proteasome |
Z-FA-FMK 是一种广谱的卤代甲基酮抑制剂,可抑制冠状病毒蛋白酶3CL,Ki 为 25.7 μM。它可以不可逆地抑制半胱氨酸蛋白酶,也可以抑制效应半胱天冬酶。 | |||
T68674 |
Vincapusine
|
Others | Others |
Vincapusine is a natural inhibitor of 3C-like protease (3CLpro), targeting SARS-CoV-2 3CLpro, SARS-CoV 3CLpro and MERS-CoV 3CLpro. | |||
T63483 |
INSCoV-614(1B)
|
Others | Others |
INSCoV-614(1B) 是一种有效的 Mpro(3CLpro) 抑制剂。蛋白酶 (PLpro 和 3CLpro) 与病毒的转录和复制有关。INSCoV-614(1B) 对 SARS-CoV-2 感染表现出研究潜力。 | |||
T9686 |
YH-53
|
Others | Others |
YH-53 是一种有效的3CLpro 抑制剂,对 SARS-CoV-1 3CLpro 和 SARS-CoV-2 3CLpro 的Ki 值分别为 6.3 nM、34.7 nM。YH-53 能够有效阻断 SARS-CoV-2 复制。YH-53 是一种具有独特苯并噻唑基酮的拟肽化合物。YH-53 具有用于研究新冠病毒的潜力。 | |||
T63462 |
INSCoV-601I(1)
|
Others | Others |
INSCoV-601I(1) 是一种有效的 Mpro(3CLpro) 抑制剂。蛋白酶 (PLpro 和 3CLpro) 与病毒的转录和复制有关。INSCoV-600I(1) 对 SARS-CoV-2 感染表现出研究潜力。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3921 |
Punicalagin
安石榴甙,安石榴苷 |
SARS-CoV; HBV | Microbiology/Virology |
Punicalagin 是一种在石榴中发现的主要鞣花单宁,是可逆且非竞争性的 3CLpro 抑制剂。Punicalagin 具有抗氧化、抗炎和抗肿瘤活性。 | |||
TN2302 |
Viscidulin III
Ganhuangenin |
Glucosidase | Metabolism |
Viscidulin III (Ganhuangenin) 存在于黄芩中,可作为α-葡萄糖苷酶抑制剂。 | |||
T80010 |
(25S)-Antcin B
|
SARS-CoV | Microbiology/Virology |
Antcin-B是3CLPro的高亲和力有效抑制剂,可用于SARS-CoV-2的研究。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-01449 |
3CLpro/3C-like Protease Protein, SARS-CoV-2, Recombinant
M Proteinase,3C-like Proteinase,3CL Protei... |
SARS-CoV-2 | E. coli |
The viral main proteinase (M pro , also called 3CL pro ), which controls the activities of the coronavirus replication complex. It functions as a cysteine protease engaging in the proteolytic cleavage of the viral precursor polyprotein to a series of functional proteins required for coronavirus replication and is considered as an appealing target for designing anti-SARS agents. 3CLpro/3C-like Protease Protein, SARS-CoV-2, Recombinant is expressed in E. coli expression system. The predicted molec... | |||
TMPY-05752 |
SARS-CoV-2 3CLpro/3C-like protease Protein (His)
|
SARS-CoV-2 | Baculovirus Insect Cells |
3C-like protease (3CLpro) is the main protease of Humann Coronavirus. 3C-like protease (3CLpro) is a key enzyme, as it cleaves several sites to produce non-structural proteins that are essential for genome replication and Coronavirus virion production, such as an RNA-dependent RNA polymerase, a helicase, ribonucleases and 3CLpro itself, from two types of polyproteins (pp1a and pp1ab). SARS-CoV 3CLpro exists as a homodimer and each protomer has an active site. SARS-CoV-2 3CLpro/3C-like protease P... | |||
TMPK-01342 |
3CLpro/3C-like Protease Protein (A191V), SARS-COV-2, Recombinant
Mpro,3CL-Mpro,3CL Protease,M Proteinase |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (A191V), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 34.8kDa and the accession number is YP_009725301.1. | |||
TMPK-01347 |
3CLpro/3C-like Protease Protein (E166A), SARS-COV-2, Recombinant
3CL-Mpro,3CL Protease,M Proteinase,Mpro |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (E166A), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 34.4kDa and the accession number is YP_009725301.1. | |||
TMPK-01343 |
3CLpro/3C-like Protease Protein (A191T), SARS-COV-2, Recombinant
3CL-Mpro,M Proteinase,Mpro,3CL Protease |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (A191T), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.8 kDa and the accession number is YP_009725301.1. | |||
TMPY-05727 |
SARS-CoV-2 3CLpro/3C-like protease Protein (His & Avi)
|
SARS-CoV-2 | E. coli |
3C-like protease (3CLpro) is the main protease of Humann Coronavirus. 3C-like protease (3CLpro) is a key enzyme, as it cleaves several sites to produce non-structural proteins that are essential for genome replication and Coronavirus virion production, such as an RNA-dependent RNA polymerase, a helicase, ribonucleases and 3CLpro itself, from two types of polyproteins (pp1a and pp1ab). SARS-CoV 3CLpro exists as a homodimer and each protomer has an active site. SARS-CoV-2 3CLpro/3C-like protease P... | |||
TMPK-01335 |
3CLpro/3C-like Protease Protein (E166V), SARS-COV-2, Recombinant
M Proteinase,Mpro,3CL Protease,3CL-Mpro |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (E166V), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.80 kDa and the accession number is YP_009725301.1. | |||
TMPK-01339 |
3CLpro/3C-like Protease Protein (S144A), SARS-COV-2, Recombinant
3CL-Mpro,M Proteinase,3CL Protease,Mpro |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (S144A), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.78 kDa and the accession number is YP_009725301.1. | |||
TMPK-01344 |
3CLpro/3C-like Protease Protein (L167F), SARS-COV-2, Recombinant
M Proteinase,Mpro,3CL-Mpro,3CL Protease |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (L167F), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 34.5kDa and the accession number is YP_009725301.1. | |||
TMPJ-01448 |
3CLpro/3C-like Protease Protein, SARS-CoV-2, Recombinant (His)
M Proteinase,3CL Proteinase |
2019-nCoV | E. coli |
The viral main proteinase (M pro , also called 3CL pro ), which controls the activities of the coronavirus replication complex. It functions as a cysteine protease engaging in the proteolytic cleavage of the viral precursor polyprotein to a series of functional proteins required for coronavirus replication and is considered as an appealing target for designing anti-SARS agents. 3CLpro/3C-like Protease Protein, SARS-CoV-2, Recombinant (His) is expressed in E. coli expression system with N-6xHis t... | |||
TMPK-01346 |
3CLpro/3C-like Protease Protein (L50F), SARS-COV-2, Recombinant
3CL-Mpro,Mpro,M Proteinase,3CL Protease |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (L50F), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.8kDa and the accession number is YP_009725301.1. | |||
TMPK-01340 |
3CLpro/3C-like Protease Protein (F140A), SARS-COV-2, Recombinant
3CL-Mpro,3CL Protease,M Proteinase,Mpro |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (F140A), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.72 kDa and the accession number is YP_009725301.1. | |||
TMPK-01337 |
3CLpro/3C-like Protease Protein (Q189K), SARS-COV-2, Recombinant
Mpro,3CL-Mpro,3CL Protease,M Proteinase |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (Q189K), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.79 kDa and the accession number is YP_009725301.1. | |||
TMPK-01338 |
3CLpro/3C-like Protease Protein (H172Y), SARS-COV-2, Recombinant
M Proteinase,3CL-Mpro,Mpro,3CL Protease |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (H172Y), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.82 kDa and the accession number is YP_009725301.1. | |||
TMPK-01341 |
3CLpro/3C-like Protease Protein (P132H), SARS-COV-2, Recombinant
3CL Protease,3CL-Mpro,Mpro,M Proteinase |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (P132H), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.8 kDa and the accession number is YP_009725301.1. | |||
TMPK-01348 |
3CLpro/3C-like Protease Protein, SARS-COV-2, Recombinant (aa 1-306)
COVID-19,3CL Protease,M Proteinase,3CL Pro... |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein, SARS-COV-2, Recombinant (aa 1-306) is expressed in E. coli expression system. The predicted molecular weight is 33.8 kDa and the accession number is YP_009725301.1. | |||
TMPK-01336 |
3CLpro/3C-like Protease Protein (L50F, E166V), SARS-COV-2, Recombinant
3CL-Mpro,3CL Protease,M Proteinase,Mpro |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (L50F, E166V), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 33.80 kDa and the accession number is YP_009725301.1. | |||
TMPK-01345 |
3CLpro/3C-like Protease Protein (L50F, E166A, L167F), SARS-COV-2, Recombinant
3CL-Mpro,Mpro,M Proteinase,3CL Protease |
SARS-CoV-2 | E. coli |
3CL protease, a viral cysteine proteinase, plays an important role in co-translational proteolytic processing of Coronavirus polyproteins. The 3CL protease cleaves as much as 11 sites in the replicase polyproteins and also releases the key replicative functions of polymerase and helicase. 3CLpro/3C-like Protease Protein (L50F, E166A, L167F), SARS-COV-2, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 34.5 kDa and the accession number is YP_009725301.1. | |||
TMPK-01384 |
SARS PLpro/papain-like protease Protein (His)
Papain-like Protease,PL-PRO,Replicase polyprotein 1a,pp1a,PL... |
SARS | E. coli |
The coronaviral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), are attractive antiviral drug targets because they are essential for coronaviral replication. Although the primary function of PLpro and 3CLpro are to process the viral polyprotein in a coordinated manner, PLpro has the additional function of stripping ubiquitin and ISG15 from host-cell proteins to aid coronaviruses in their evasion of the host innate immune responses. SARS PLpro/papain-like protease Protein (... | |||
TMPK-01352 |
SARS-CoV-2 PLpro/papain-like protease Protein (His & Avi)
Plpro,PL2-PRO,pp1a,nsp1,Replicase polyprotein 1a,Papain-like... |
SARS | E. coli |
The coronaviral proteases, papain-like protease (PLpro) and 3C-like protease (3CLpro), are attractive antiviral drug targets because they are essential for coronaviral replication. Although the primary function of PLpro and 3CLpro are to process the viral polyprotein in a coordinated manner, PLpro has the additional function of stripping ubiquitin and ISG15 from host-cell proteins to aid coronaviruses in their evasion of the host innate immune responses. SARS-CoV-2 PLpro/papain-like protease Pro... | |||
TMPJ-01428 |
SARS-CoV-2 NSP8 Protein (His)
SARS-CoV 2 nsp8 |
SARS-CoV-2 | E. coli |
Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.Nsp8 was shown to have RNA-dependen... | |||
TMPJ-01431 |
SARS-CoV-2 Papain-Like Protease Protein
PLpro,PL-PRO,pp1a,Replicase polyprotein 1a,Papain-like Prote... |
SARS-CoV-2 | E. coli |
Replication of severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) requires proteolytic processing of the replicase polyprotein by two viral cysteine proteases, a chymotrypsin-like protease (3CLpro) and a papain-like protease (PLpro). These proteases are important targets for development of antiviral drugs that would inhibit viral replication and reduce mortality associated with outbreaks of SARS-CoV. PLpro is a cysteine protease located within the non-structural protein 3 (NS3) sect... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMIH-0394 |
Nirmatrelvir-d9
|
||
Nirmatrelvir-d9 是 Nirmatrelvir 的氘代化合物。Nirmatrelvir 的 CAS 号为 2628280-40-8。PF-07321332 是一种有效的口服活性SARS-CoV 3CLPRO抑制剂,对 SARS-CoV-2 病毒有针对性,可研究 COVID-19。它是一种胰蛋白酶样蛋白酶抑制剂,可抑制气道上皮钠通道功能。 | |||
TMID-0082 |
Lopinavir-d8
|
||
Lopinavir-d8 是 Lopinavir 的氘代化合物。Lopinavir 的 CAS 号为 192725-17-0。Lopinavir 是一种选择性肽模拟 HIV-1 蛋白酶的高效抑制剂。它通过阻止 HIV-1 的成熟而起作用,从而阻断其感染性。它也是SARS-CoV 3CLpro的抑制剂。 | |||
TMIJ-0076 |
Ritonavir-13C-d3
|
||
Ritonavir-13C-d3 是 Ritonavir 的 13C 和氘代化合物。Ritonavir 的 CAS 号为 155213-67-5。Ritonavir 是一种 HIV 蛋白酶抑制剂,可研究 HIV 感染和 AIDS 。它也是SARS-CoV 3CLpro的抑制剂,IC50为 1.61 μM。 |